A detailed history of Polaris Wealth Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Polaris Wealth Advisory Group, LLC holds 1,775 shares of AMGN stock, worth $522,790. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,775
Holding current value
$522,790
% of portfolio
0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $388,103 - $481,841
1,775 New
1,775 $477,000
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $86,251 - $105,126
382 Added 26.98%
1,798 $434,000
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $28,057 - $31,643
-125 Reduced 8.11%
1,416 $329,000
Q2 2022

Jul 12, 2022

BUY
$230.71 - $256.74 $9,689 - $10,783
42 Added 2.8%
1,541 $375,000
Q1 2022

Apr 19, 2022

BUY
$219.27 - $242.57 $64,246 - $71,073
293 Added 24.3%
1,499 $377,000
Q3 2021

Oct 18, 2021

SELL
$212.27 - $248.7 $1,273 - $1,492
-6 Reduced 0.5%
1,206 $252,000
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $70,074 - $77,742
300 Added 32.89%
1,212 $299,000
Q1 2021

Apr 19, 2021

BUY
$221.91 - $258.6 $202,381 - $235,843
912 New
912 $227,000
Q4 2020

Jan 25, 2021

SELL
$216.38 - $257.67 $206,642 - $246,074
-955 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$197.81 - $242.74 $188,908 - $231,816
955 New
955 $244,000
Q4 2018

Jan 17, 2019

SELL
$178.4 - $208.25 $142,720 - $166,600
-800 Closed
0 $0
Q3 2018

Oct 19, 2018

BUY
$185.29 - $208.89 $148,232 - $167,112
800 New
800 $166,000
Q2 2018

Jul 09, 2018

SELL
$166.05 - $186.51 $132,840 - $149,208
-800 Closed
0 $0
Q1 2018

Apr 09, 2018

BUY
$169.43 - $198.0 $135,544 - $158,400
800 New
800 $136,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Polaris Wealth Advisory Group, LLC Portfolio

Follow Polaris Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Wealth Advisory Group, LLC with notifications on news.